Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial compares the fixed-dose combination of etoricoxib and cyanocobalamin to etoricoxib alone for acute low back pain, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)
  • Etoricoxib/Cyanocobalamin (etoricoxib + cyanocobalamin)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Acute Low-back Pain | Phase 3 | Status: COMPLETED